Effects of an intradialytic cardiovascular rehabilitation program on functional capacity and cardiac function: ICRP trial

Abstract Introduction: Chronic kidney disease (CKD) is a worldwide public health problem associated with an increased risk of death from cardiovascular complications. Although previous studies have described significant improvements in exercise in functional capacity and quality of life in patients with end-stage kidney disease (ESKD), there is a lack of studies that propose to assess its impact on cardiac function using transthoracic echocardiogram (ECHO). In addition, most of the intradialytic exercise protocols are inconsistent, and incomplete regarding their intensity prescription, time of intervention, and monitoring. Methods: The present study aims to evaluate the effects of an intradialytic cardiovascular rehabilitation protocol (ICRP) using medium intensity aerobic exercises, for 30 min. on cardiac function and functional capacity. In this 6-month longitudinal study, heart rate (HR), systolic (SBP) and diastolic (DBP) blood pressure, peripheral oxygen saturation (SpO2) and modified Borg scale will be analyzed in all HD sessions. The cardiac function will be evaluated by left ventricular ejection fraction (LVEF) through ECHO; functional capacity by the six-minute walk test (6MWT); quality of life through the SF-36 questionnaire and routine laboratory tests and KT/Vsp calculation before and after the ICRP. Conclusion: ICRP protocol will be examined and is expected to improve cardiac function, functional capacity, and quality of life in ESKD patients on hemodialysis.

Avaliação da modulação autonômica da frequência cardíaca de pacientes com doença renal crônica em hemodiálise: estudo preliminar / Evaluación de la modulación autónoma de la frecuencia cardíaca en pacientes con enfermedad renal crónica sometidos a hemodiálisis: estudio preliminar / Evaluation of the autonomic heart rate modulation of patients with chronic renal disease in hemodyalysis: preliminare study

RESUMO A doença renal crônica (DRC) é definida como dano à função renal. Doentes renais crônicos atingem alta prevalência de morte por eventos cardiovasculares antes dos estágios finais, sendo maior a mortalidade em estágio dialítico, em que é evidenciado um desequilíbrio autonômico. Objetivamos avaliar a modulação simpatovagal de pacientes com DRC em tratamento de hemodiálise ambulatorial. Foram avaliados 23 pacientes, divididos em: Grupo DRC com DRC no estágio 5D (DRC-5D) em tratamento regular de hemodiálise ambulatorial; Grupo-controle com indivíduos saudáveis. A variabilidade da frequência cardíaca (VFC) foi coletada por um cardiofrequencímetro e analisada por índices lineares do domínio do tempo e do domínio da frequência. 14 pacientes no Grupo DRC com média de idade 48±16; e 9 pacientes saudáveis no Grupo-controle com média de idade 64±5. Nos resultados pelo domínio de tempo, o Grupo DRC mostrou valores significativamente maiores da frequência cardíaca (FC) comparado ao Grupo-controle (83,49±13,09 bpm vs. 67,88±9,43 bpm). Todavia, os índices média dos intervalos R-R (735,82±121,54 ms vs. 898,94±123,58 ms), RMSSD (11,75±11,86 ms vs. 20,03±6,80 ms), SDNN (17,06±9,81ms vs. 28,42±7,62 ms) do Grupo DRC mostraram valores significativamente menores comparados aos do Grupo-controle, respectivamente. Nos resultados pelo domínio da frequência, o Grupo DRC mostrou valores significativamente menores em comparação ao Grupo-controle nos índices BFab (129,7±184,3 ms vs. 262,31±168,15 ms) e AFab (82,70±227,66 ms vs. 180,77±119,85 ms). Pacientes com DRC em hemodiálise apresentaram redução da modulação parassimpática quando comparados com indivíduos saudáveis, sugerindo prejuízo do balanço simpatovagal e, consequente, disfunção autonômica cardíaca.

RESUMEN La enfermedad renal crónica (ERC) se define como la pérdida de la función renal. Los pacientes renales crónicos tienen una alta prevalencia de muerte por eventos cardiovasculares antes de la etapa final, con mayor mortalidad en la etapa de diálisis, en la que se evidencia un desequilibrio autonómico. Este estudio tuvo como objetivo evaluar la modulación simpatovagal de pacientes con ERC sometidos a tratamiento de hemodiálisis ambulatoria. Se evaluaron 23 pacientes, lo cuales fueron divididos en: Grupo ERC con ERC en etapa 5D (ERC-5D) en tratamiento de hemodiálisis ambulatoria regular; Grupo de control con individuos sanos. Para identificar la variabilidad de la frecuencia cardíaca (VFC) se utilizó un monitor de frecuencia cardíaca y los datos obtenidos fueron analizados por los índices lineales de tiempo y de dominio de frecuencia. En el grupo ERC 14 pacientes tenían un promedio de edad de 48±16 años; y en el grupo control 9 pacientes sanos tenían un promedio de edad de 64±5. En los resultados para el dominio del tiempo, el grupo ERC mostró valores significativamente más altos de frecuencia cardíaca (FC) en comparación con el grupo control (83,49±13,09 lpm vs. 67,88±9,43 lpm). Sin embargo, los índices medios de los intervalos R-R (735,82±121,54 ms vs. 898,94±123,58 ms), RMSSD (11,75±11,86 ms vs. 20,03±6,80 ms), SDNN (17,06±9,81 ms vs. 28,42±7,62 ms) del grupo ERC demostraron valores significativamente más bajos en comparación con el grupo control, respectivamente. En los resultados para el dominio de la frecuencia, en el grupo ERC se obtuvo valores significativamente más bajos en comparación con el grupo control en los índices BFab (129,7±184,3 ms vs. 262,31±168,15 ms) y AFab (82,70±227,66 ms vs. 180,77±119,85 ms). Los pacientes con ERC sometidos a hemodiálisis mostraron una modulación parasimpática reducida en comparación con los individuos sanos, lo que sugiere un deterioro del equilibrio simpaticovagal y, en consecuencia, una disfunción autonómica cardíaca.

ABSTRACT Chronic kidney disease (CKD) is defined as damage to kidney function. Patients have high prevalence of death by cardiovascular events before the final stages of the disease, with higher mortality in dialytic stage, in which autonomic imbalance is evidenced. This study seeks to evaluate sympathovagal modulation of patients with CKD undergoing hemodialysis treatment. We evaluated 23 subjects, divided into: CDK-group with CKD-stage 5D in regular hemodialysis treatment; and Control-group with healthy individuals. Heart rate variability (HRV) was collected by a heart rate monitor and analyzed by linear time domain and frequency domain indices. CDK-group had 14 patients, mean age of 48±16; and Control-group had 9 healthy patients, mean age of 64±5. In the time domain, CDK-group showed significantly higher heart rate values compared with Control-group (83.49±13.09 bpm vs. 67.88±9.43 bpm). However, the mean indices of the R-R intervals (735.82±121.54 ms vs. 898.94±123.58 ms), RMSSD (11.75±11.86 ms vs. 20.03±6.80 ms), and SDNN (17.06±9.81 ms vs. 28.42±7.62 ms) from CDK-group showed significantly lower values compared with Control-group. In frequency domain results, CDK-group showed significantly lower values compared with Control-group in LFab (129.7±184.3 ms vs. 262.31±168.15 ms) and HFab (82.70±227.66 ms vs. 180.77±119.85 ms). Patients with CKD on hemodialysis had reduced parasympathetic modulation compared with healthy subjects, suggesting impairment of the sympathovagal balance and, consequently, cardiac autonomic dysfunction.

Beneficial effects of intradialytic cardiopulmonary rehabilitation.

INTRODUCTION: Patients on hemodialysis (HD) present high mortality from cardiovascular complications and high morbidity, including decreasing functional capacity and quality of life. OBJECTIVE: To analyze clinical and laboratory responses of patients in HD to intradialytic cardiopulmonary rehabilitation on an outpatient basis. METHODS: We evaluated 14 patients in a prospective study for 8 months using cardiopulmonary rehabilitation protocol (CRehab) consisted of intradialytic aerobic exercise with a cycle ergometer. We analyzed heart rate (HR), systolic (SBP) and diastolic blood pressure (DBP), peripheral oxygen saturation (SpO2) and modified Borg scale. We evaluated cardiac function by echocardiogram, functional capacity by six minutes walk test (6MWT), and quality of life by SF-36 survey, before and after CRehab. Biochemical data and KT/Vsp were collected form medical records. RESULTS: During CRehab, the results of HR, SBP, DBP, SpO2 and Borg scale showed no significant changes. 6MWT test showed progressive increase in the distance covered (p < 0.001) as well as a reduction in the scale of Borg post-6MWT (p = 0.009). There was no significant change in any biochemical data or in KT/Vsp. There was increase in left ventricular ejection from 65.7 ± 10.2% to 73.6 ± 10.1% (p = 0.028) and in left ventricular diastolic diameter (p = 0.027). According to SF-36 survey, patients showed improvement in three areas: physical role functioning (p = 0.012), bodily pain (p = 0.007) and vitality (p = 0.009). CONCLUSION: The intradialytic CRehab applied in this population was safe and allowed objective improvement of functional capacity and exercise tolerance, subjective improvement in the perception of effort, significant increase in cardiac function and better quality of life in different domains.

Beneficial effects of intradialytic cardiopulmonary rehabilitation / Efeitos benéficos da reabilitação cardiopulmonar intradialítica

Abstract Introduction: Patients on hemodialysis (HD) present high mortality from cardiovascular complications and high morbidity, including decreasing functional capacity and quality of life. Objective: To analyze clinical and laboratory responses of patients in HD to intradialytic cardiopulmonary rehabilitation on an outpatient basis. Methods: We evaluated 14 patients in a prospective study for 8 months using cardiopulmonary rehabilitation protocol (CRehab) consisted of intradialytic aerobic exercise with a cycle ergometer. We analyzed heart rate (HR), systolic (SBP) and diastolic blood pressure (DBP), peripheral oxygen saturation (SpO2) and modified Borg scale. We evaluated cardiac function by echocardiogram, functional capacity by six minutes walk test (6MWT), and quality of life by SF-36 survey, before and after CRehab. Biochemical data and KT/Vsp were collected form medical records. Results: During CRehab, the results of HR, SBP, DBP, SpO2 and Borg scale showed no significant changes. 6MWT test showed progressive increase in the distance covered (p < 0.001) as well as a reduction in the scale of Borg post-6MWT (p = 0.009). There was no significant change in any biochemical data or in KT/Vsp. There was increase in left ventricular ejection from 65.7 ± 10.2% to 73.6 ± 10.1% (p = 0.028) and in left ventricular diastolic diameter (p = 0.027). According to SF-36 survey, patients showed improvement in three areas: physical role functioning (p = 0.012), bodily pain (p = 0.007) and vitality (p = 0.009). Conclusion: The intradialytic CRehab applied in this population was safe and allowed objective improvement of functional capacity and exercise tolerance, subjective improvement in the perception of effort, significant increase in cardiac function and better quality of life in different domains.

Resumo Introdução: Pacientes em hemodiálise (HD) têm alta mortalidade e morbidade por complicações cardiovasculares, inclusive por redução da capacidade funcional e qualidade de vida. Objetivo: Analisar a evolução clínica e laboratorial de pacientes em HD ambulatorial submetidos à reabilitação cardiopulmonar (RCP) intradialítica. Métodos: Avaliamos 14 pacientes em um estudo prospectivo por 8 meses, utilizando protocolo de RCP com exercícios aeróbicos intradialíticos. Analisamos frequência cardíaca (FC), pressão arterial sistólica (PAS) e diastólica (PAD), saturação periférica de oxigênio (SpO2) e escala de Borg modificada em todas as sessões de HD. Avaliamos função cardíaca por ecocardiograma, capacidade funcional (CF) pelo teste de caminhada de seis minutos (TC6M), e qualidade de vida pelo Questionário SF-36, antes e depois da RCP. Dados bioquímicos e de Kt/Vsp foram coletados dos prontuários. Resultados: Durante a RCP, os resultados de FC, PAS, PAD, SpO2 e escala de Borg não mostraram alterações significativas. No TC6M observamos aumento progressivo da distância percorrida (p < 0,001) e redução na escala de Borg pós-TC6M entre D0-D180 (p = 0,009). Não houve alteração significativa nos testes bioquímicos e no KT/Vsp. Houve aumento na fração de ejeção de 65,7 ± 10,2 para 73,6 ± 10,1% (p = 0,028) e no diâmetro diastólico do ventrículo esquerdo (p = 0,027). No questionário SF-36, houve melhora significativa nos domínios: limitação física (p = 0,012), dor (p = 0,007) e vitalidade (p = 0,009). Conclusão: A RCP intradialítica nesta população foi segura e permitiu melhora objetiva da CF e tolerância ao exercício, melhora subjetiva na percepção do esforço, aumento significativo da função cardíaca, bem como melhoria na qualidade de vida em diferentes domínios.